Pregnancy Complication Clinical Trial
— ObeDiOfficial title:
Study of Role of Mononuclear Cells of Maternal Peripheric Blood in Human Myometrial Primar Cell Lines Differentiation Toward a Contratyl Phenotype: Influence of Preconceptional Obesity
Verified date | January 2013 |
Source | Centre Hospitalier Universitaire Dijon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to improve the understanding of cellular mecanism involved in delivery disorders in obese women, first by characterizing the hyperplasia phenomenon of myometrail cells induced by inflammatory stimulation (Il-1B), then by studying the role of blood mononuclear cells, of leptine and of obese women sera to interfere with the transition of myometrial cells toward hyperplasia phenotype.
Status | Completed |
Enrollment | 38 |
Est. completion date | January 15, 2016 |
Est. primary completion date | January 15, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Informed consent signed - Patient affiliated with a social security scheme - In front of for obstetrical reasons to give birth by caesarean section (scheduled caesarean section) - Or a woman who is not obese in labour and needs to undergo a cesarean section - No obvious infectious context - Age > 18 years old Exclusion Criteria: - Obvious inflammatory or autoimmune diseases - Suspected or confirmed infectious context, including virale infection VIH, VHC, VHB - Coagulation disorders |
Country | Name | City | State |
---|---|---|---|
France | Clinique Sainte Marthe | Dijon | |
France | Maternité du CHU de Dijon | Dijon | Bourgogne |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire Dijon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measuring the expression level of markers (Gama actine, Desmine, Connexine-43, and Ocytocine receptor) by Westernblotting | Demonstrate in vitro the capacity of a Il-1B stimulus to induce the differentiation of the myometrial cells toward a hyperplasia phenotype, and that the answer depends on whether this is cells from normal weight women or obese women before conception. | up to 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03626597 -
Community-based Provision of Urine Pregnancy Tests as Linkage to Reproductive Health Services
|
N/A | |
Enrolling by invitation |
NCT01019785 -
Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial
|
Phase 3 | |
Recruiting |
NCT02372487 -
Sildenafil Citrate Therapy for Oligohydramnios
|
N/A | |
Completed |
NCT02362399 -
Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses
|
N/A | |
Completed |
NCT00901758 -
Intravenous (IV) Nitroglycerin for Versions in Multiparous Women
|
N/A | |
Recruiting |
NCT06113237 -
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
|